Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
VIVS

VivoSim Labs (VIVS) stock: insider trades, news & valuation

Health Care · Net selling
Close · Oct 9, 2026 $0.18 +0.0% on the day -94.6% over 12 months 52-week range $0.18 – $3.33

Share price and insider trades

VIVS closeInsider buyInsider sale
01234NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $2,800 on 2026-08-31 · Tony Serge LialinSold $7,316 on 2025-11-17 · David Gobel
Bought, 12 months$0
Sold, 12 months$7K
Insiders buying0
Insiders selling1

VivoSim Labs insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $7K of VIVS stock on the open market.

VIVS insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $7K sold (1 trades)Q4 2025Q1 2026Q2 2026Q3 2026: $3K bought (1 trades)$3KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$3K1—0
Q2 2026—0—0
Q1 2026—0—0
Q4 2025—0$7K1

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$3.0MBiotechnology
Profit margin0.0%Revenue growth -51.4%
Volume vs. 50-day0.2×Last 5 sessions
Insiders' paper profit−$1KOn all tracked purchases -35.7%

Summary

Over the past 12 months, 0 VivoSim Labs, INC. insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $7K. 0 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

VIVS stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 1SEC Tony Serge LialinChief Commercial Officer Buy 10,000new position $0.28 $3K -35.7% —
Nov 19SEC David GobelDirector Sell 3,266 $2.24 $7K -92.0% —

Insiders at VivoSim Labs, INC.

InsiderBoughtSoldLast filingScore
Tony Serge LialinChief Commercial Officer $3K — Sep 1, 2026 —
David GobelDirector — $7K Nov 19, 2025 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

VIVS stock: common questions

Are VivoSim Labs, INC. insiders buying VIVS stock?

In the past 12 months, 0 insiders reported open-market purchases of VIVS worth $0. The latest was Chief Commercial Officer Tony Serge Lialin bought $3K of VIVS at $0.28 — first open-market purchase in our records; opens a new position.

Are VivoSim Labs, INC. insiders selling VIVS stock?

1 insiders reported sales worth $7K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is VIVS's 52-week range?

Over the past year VIVS has traded between $0.18 and $3.33. It last closed at $0.18 on Oct 9, 2026.